Spectrum Bias and Individual Strengths of SARS-CoV-2 Serological Tests—A Population-Based Evaluation

Antibody testing for determining the SARS-CoV-2 serostatus was rapidly introduced in early 2020 and since then has been gaining special emphasis regarding correlates of protection. With limited access to representative samples with known SARS-CoV-2 infection status during the initial period of test...

Descripción completa

Detalles Bibliográficos
Autores principales: Einhauser, Sebastian, Peterhoff, David, Niller, Hans Helmut, Beileke, Stephanie, Günther, Felix, Steininger, Philipp, Burkhardt, Ralph, Heid, Iris M., Pfahlberg, Annette B., Überla, Klaus, Gefeller, Olaf, Wagner, Ralf
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8534748/
https://www.ncbi.nlm.nih.gov/pubmed/34679541
http://dx.doi.org/10.3390/diagnostics11101843

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8534748/
https://www.ncbi.nlm.nih.gov/pubmed/34679541
http://dx.doi.org/10.3390/diagnostics11101843

Ejemplares similares